We have the expertise within MENTOR and access to individuals who designed, implemented and evaluated a number of the most significant pharmaceutical track & trace pilots and trials in recent years. (Irish Blood Derivatives, EU Bridge, MeditraQ Centre of Excellence (amongst others)

We believe that no other organisation has access to such skilled individuals
who are at the forefront of integrating track & trace developments within the pharmaceutical and related industries.

One of the key ‘First Steps’ in creating a track & trace solution that meets
your companies present & future needs is to start with a line evaluation,
in other words esatblishing your current coding and serialisation capabilties. Without this you will never be able to understand how to plan the various steps you will need to take to develop your track, trace and authentication solution.

The ‘Team’ at MENTOR have not only successfully developed trials and
pilots to global industry standards but were the first – and so far, the only
group of individuals - to evaluate and analyse the existing product line
and then write the URS, design, implement, install and operate a
fully integrated, fully functioning, fully validated pharmaceutical
production line to GAMP, ISO and 21 CFR Part 11 in 2008.

Also, having built a number of different types of line the experts at
MENTOR can advise on technical, performance and standards issues
from a practical not just a theoretical standpoint.

Remenber, a number of the members of the MENTOR team
are working on standards and compliance developments for
major global organisations and regulatory bodies.